The effect of furosemide in the prevention of contrast-induced nephropathy in STEMI patients undergoing Percutaneous Coronary Intervention (PCI)

The effect of furosemide in the prevention of contrast-induced nephropathy in STEMI (ST) Elevation Myocardial Infarction patients undergoing Percutaneous Coronary Intervention (PCI) referred to Golestan Hospital between 2023-2024

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230312057694N1

Enrollment

234

Registered

2023-05-22

Start date

2023-03-20

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Myocardial infarction. Condition 2: Contrast-induced nephropathy. Acute myocardial infarction,unspecified

Interventions

Intervention 1: Intervention group: Recipients of 0.5 mg/kg formeside within one hour after Percutaneous Coronary Intervention (PCI) as a single dose and 1 mg/kg/h of normal saline serum within 24 ho

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Those who are willing to participate in the study Patients whose clinical information is complete Patients whose disease has been confirmed as STEMI and are candidates for angiography and angioplasty

Exclusion criteria

Exclusion criteria: Patients who do not agree to participate in the study Patients whose clinical information is not complete Patients with heart failure Dialysis patients who do not pass urine

Design outcomes

Primary

Measure	Time frame
Renal function and occurrence of renal disorders after the use of contrast. Timepoint: After a period of 24 and 72 hours after the injection of furosemide and serum. Method of measurement: Test: Blood Urea Nitrogen(Bun),Creatinine(Cr), Glomerular Filtration Rate (GFR).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mustafa Ariafar

Ahvaz University of Medical Sciences

ariafar-m@ajums.ac.ir+98 61 3374 3966

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026